P1446: PHASE I STUDY DATA UPDATE OF PHE885, A FULLY HUMAN BCMA-DIRECTED CAR-T CELL THERAPY MANUFACTURED USING THE T-CHARGETM PLATFORM FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM)

Bibliographic Details
Main Authors:	A. S. Sperling, S. Nikiforow, B. Derman, O. Nadeem, C. Mo, J. Laubach, K. Anderson, A. Alonso, S.-Y. Im, S. Ikwgawa, R. Prabhala, D. Hernandez Rodriduez, H. Daley, K. L. Shaw, Y. Arihara, S. Ansari, D. S. Quinn, D. Pearson, A. Hack, L. Treanor, D. Bu, J. Mataraza, L. Rispoli, M. Credi, J. Ritz, A. Jakubowiak, S. De Vita, N. Munshi
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000848640.53562.8f

Internet